Mr. Speaker, clearly, everything is not okay. The Conservative government made promises and created high expectations with regard to GSK's ability to distribute enough vaccine. The problem is that GSK did not hold up its end of the bargain.
Why did it not hold up its end of the bargain? That is an interesting question. It did not do so because all of a sudden, it turned out that the government did not plan for the production of non-adjuvanted vaccine, or at least, failed to consider its usefulness. What did the government do? It paid dearly for vaccine from Australia and asked GSK—in a politically motivated and amateurish decision—to alter its production line to produce non-adjuvanted vaccine when it suddenly realized that it had nothing to give the highest-risk group, pregnant women.
It is clear that everything is not okay. Someone is hiding the truth. Whether that someone is the government, well, if one looks at how it has handled this matter from the beginning, some serious questions have to be asked.
Not long ago, there was talk of supplying 3.5 million doses per week, if I am not mistaken, but actual production has been dramatically lower. So there was a problem and, as I was saying, the problem was with the shift in production priority. From one day to the next, someone decided to change production over to the non-adjuvanted vaccine. Since the very beginning, we have been talking about the underlying problem, which is that there was one single supplier.
I see that, unfortunately, I have very little time left. If only the government had dealt with other pharmaceutical companies, they could have helped meet the need in this kind of situation, and we would not be here debating this issue today.